Actuate Therapeutics, Inc.
Actuate Therapeutics is a publicly traded United States biotechnology company developing investigational cancer medicines, including programs based on modulation of GSK-3 beta. The company is headquartered in Fort Worth, Texas, and its common shares are registered on Nasdaq under ACTU. In October 2026, it disclosed Nasdaq continued-listing deficiency notices concerning minimum bid price and market value requirements. The notices expressly stated that trading continued and did not constitute immediate delisting, although compliance was unresolved.
Company at a glance
Corporate information
- Company entity
- Actuate Therapeutics, Inc.
- Headquarters / principal office
- United States
- Founded
- Not verified
- Ownership / capital status
- Publicly tradedPublicly listed
- Official corporate reference
- https://actuatetherapeutics.com/
- LinkedIn company page
- Independent company page not verified
Profile review: 2026-11-08 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Listed issuer and R&D focus
Nasdaq: ACTU
GSK-3beta inhibition · small-molecule oncology
oncology
Last independently verified:
Disease tags match recorded text mentions and require program-level verification.
Technology, programs & evidence
Actuate Therapeutics is a publicly traded United States biotechnology company developing investigational cancer medicines, including programs based on modulation of GSK-3 beta. The company is headquartered in Fort Worth, Texas, and its common shares are registered on Nasdaq under ACTU. In October 2026, it disclosed Nasdaq continued-listing deficiency notices concerning minimum bid price and market value requirements. The notices expressly stated that trading continued and did not constitute immediate delisting, although compliance was unresolved.
Business, technology & evidence
- SecuritiesNasdaq: ACTU
Individual program detail is not recorded. Consult the original sources below.
Related news & literature
Company-name matches are discovery leads; verify entity identity and transaction roles in the original source.
Showing 0 / 0 related items
No cataloged update explicitly mentions this company.
Same-field reading (not company-specific)
Research this company together
Discussions are for signed-in members. Personal notes remain separate from company research.
Sign in to joinSources & open questions
- Official issuer and R&D disclosure · Actuate Therapeutics, Inc. ↗Actuate Therapeutics, Inc. ·
- Official issuer and R&D disclosure · Actuate Therapeutics, Inc. ↗Actuate Therapeutics, Inc. ·
- Official issuer and R&D disclosure · Actuate Therapeutics, Inc. ↗Actuate Therapeutics, Inc. ·
Inclusion is not endorsement or partner qualification. Assess company claims, clinical evidence, and project-specific capabilities separately.